Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.
Clinical trial NCT03976882 · COMPLETED
Trial details
- NCT number
- NCT03976882
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-06
- Primary completion
- 2023-02-22
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.